We are excited to announce that Annalisa Landi, a TEDDY representative and researcher at Fondazione Gianni Benzi Onlus has been appointed as Steering Group member of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) for the term 2024-2026. The ENCePP is a network coordinated by the European Medicines Agency, aimed to strengthen
TEDDY Network’s young persons advisory groups (YPAG) from Albania (KIDS Albania) and Italy (KIDS Bari) have participated at the 2023 International Children’s Advisory Network (iCAN) Summit that was held in La Jolla, San Diego, California from July 10 to July 14, 2023. During these intense and productive 5 days of meeting, participants had the opportunity
TEDDY is organising the “Third Paediatric Expert Patients Training Workshop” in collaboration with EURORDIS and the Sant Joan de Déu Research Foundation in the framework of the European Joint Programme on Rare Diseases (EJPRD). This year, the paediatric training workshop will take place in Barcelona, Spain, from Wednesday 21st to Friday 23rd June 2023. This
This International Course organized by the Medical University of Gdańsk, in collaboration with EURORDIS and EJP RD, and the support of ACCURARE Turkey and ISS Italy, will be held in Gdańsk, Poland on 26 to 27 October 2023. The course aims to teach participants the following competences through plenary presentations and interactive sessions: Presentation,
This 28 February is Rare Disease Day (RDD), an opportunity to celebrate people living with rare diseases and to raise awareness of these disorders. TEDDY Network, through its Young Persons Advisory Groups (YPAGs) (KIDS Albania, KIDS Bari, and KIDS Hellas) and the TEDDY Kids international group, is happy to participate in several activities planned to raise
The closing report of the European Medicines Agency (EMA) and European Commission (DG Health and Food Safety) action plan on paediatrics has been recently published. During the past four years, several initiatives were taken to increase the efficiency of the paediatric regulatory processes and promote the development of paediatric medicines. The paediatric action plan has
Dr. Jeremy Faust, editor-in-chief of MedPage Today has interviewed Dr. Zachary Rubin, allergist and immunologist of Oak Brook Allergists in Illinois, to discuss the lasting effects of COVID-19 on pediatric health. According to Dr. Rubin there is not a single clinical phenotype for patients with long COVID. Patients can present: brain fog and other neurological
The workshop, co-organised by the European network of paediatric research at the EMA (Enpr-EMA) and conect4children (c4c), was held virtually on October 3, 2022. Participants included members of Enpr-EMA and of c4c, members of the European Medicines Agency’s (EMA) Paediatric Committee (PDCO) as well as members of EMA’s Paediatric Medicines Office, along with invitees representing
Dr Donato Bonifazi, in his role as iCAN Advisory Board Member, has participated in the International Children’s Advisory Network (iCAN), “Becoming a Leader” short videos series to talk about the challenges of conducting clinical trials for and with the paediatric population. According to Dr Bonifazi “we’ll not only need to adapt adults' medicines to
The European Forum for Good Clinical Practice (EFGCP) Children’s Medicines Working Party (CMWP) has developed an open-access “Adolescent Inclusion Decision Tree” to be used by trial sponsors, trial investigators, IRBs/ethics committees, and health regulatory agencies, when a trial with age-inclusive trial design is being explored, developed or reviewed. The tool outlines over-arching principles for consideration,